These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 2075373

  • 21. Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis.
    Yudoh K, Matsuno H, Nakazawa F, Yonezawa T, Kimura T.
    Arthritis Rheum; 2000 Mar; 43(3):617-27. PubMed ID: 10728756
    [Abstract] [Full Text] [Related]

  • 22. Clonal dominance among T-lymphocyte infiltrates in arthritis.
    Stamenkovic I, Stegagno M, Wright KA, Krane SM, Amento EP, Colvin RB, Duquesnoy RJ, Kurnick JT.
    Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1179-83. PubMed ID: 2963340
    [Abstract] [Full Text] [Related]

  • 23. BiP, a putative autoantigen in rheumatoid arthritis, stimulates IL-10-producing CD8-positive T cells from normal individuals.
    Bodman-Smith MD, Corrigall VM, Kemeny DM, Panayi GS.
    Rheumatology (Oxford); 2003 May; 42(5):637-44. PubMed ID: 12709539
    [Abstract] [Full Text] [Related]

  • 24. Interferon-gamma-inducing activity of interleukin-18 in the joint with rheumatoid arthritis.
    Yamamura M, Kawashima M, Taniai M, Yamauchi H, Tanimoto T, Kurimoto M, Morita Y, Ohmoto Y, Makino H.
    Arthritis Rheum; 2001 Feb; 44(2):275-85. PubMed ID: 11229457
    [Abstract] [Full Text] [Related]

  • 25. Interleukin-2 in rheumatoid arthritis: production of and response to interleukin-2 in rheumatoid synovial fluid, synovial tissue and peripheral blood.
    Combe B, Pope RM, Fischbach M, Darnell B, Baron S, Talal N.
    Clin Exp Immunol; 1985 Mar; 59(3):520-8. PubMed ID: 3921298
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Cytokine production by synovial T cells in rheumatoid arthritis.
    Steiner G, Tohidast-Akrad M, Witzmann G, Vesely M, Studnicka-Benke A, Gal A, Kunaver M, Zenz P, Smolen JS.
    Rheumatology (Oxford); 1999 Mar; 38(3):202-13. PubMed ID: 10325658
    [Abstract] [Full Text] [Related]

  • 30. Multiple mechanisms support oligoclonal T cell expansion in rheumatoid synovitis.
    Rittner HL, Zettl A, Jendro MC, Bartz-Bazzanella P, Goronzy JJ, Weyand CM.
    Mol Med; 1997 Jul; 3(7):452-65. PubMed ID: 9260157
    [Abstract] [Full Text] [Related]

  • 31. Evidence for enhanced interleukin 2 (IL-2) secretion and IL-2 receptor presentation by synovial fluid lymphocytes in rheumatoid arthritis.
    Lemm G, Warnatz H.
    Clin Exp Immunol; 1986 Apr; 64(1):71-9. PubMed ID: 3089651
    [Abstract] [Full Text] [Related]

  • 32. Evidence for activation of rheumatoid synovial T lymphocytes--development of rheumatoid T cell clones.
    Førre O, Waalen K, Natvig JB, Kjeldsen-Kragh J.
    Scand J Rheumatol Suppl; 1988 Apr; 76():153-60. PubMed ID: 3075072
    [Abstract] [Full Text] [Related]

  • 33. Enhanced co-stimulatory ability of synovial fluid accessory cells in rheumatoid arthritis.
    Robertson SE, Young SP, Viner NJ, Bacon PA.
    Br J Rheumatol; 1997 Apr; 36(4):413-9. PubMed ID: 9159532
    [Abstract] [Full Text] [Related]

  • 34. The efficacy of abatacept in reducing synovial T cell activation by CD1c myeloid dendritic cells is overruled by the stimulatory effects of T cell-activating cytokines.
    Moret FM, Bijlsma JW, Lafeber FP, van Roon JA.
    Arthritis Rheumatol; 2015 Mar; 67(3):637-44. PubMed ID: 25469671
    [Abstract] [Full Text] [Related]

  • 35. Rheumatoid arthritis serum or synovial fluid and interleukin 2 abnormally expand natural killer-like cells that are potent stimulators of IgM rheumatoid factor.
    Santiago-Schwarz F, Kay C, Panagiotopoulos C, Carsons SE.
    J Rheumatol; 1992 Feb; 19(2):223-8. PubMed ID: 1378496
    [Abstract] [Full Text] [Related]

  • 36. Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation.
    Kotake S, Sato K, Kim KJ, Takahashi N, Udagawa N, Nakamura I, Yamaguchi A, Kishimoto T, Suda T, Kashiwazaki S.
    J Bone Miner Res; 1996 Jan; 11(1):88-95. PubMed ID: 8770701
    [Abstract] [Full Text] [Related]

  • 37. A dual action of rheumatoid arthritis synovial fibroblast IL-15 expression on the equilibrium between CD4+CD25+ regulatory T cells and CD4+CD25- responder T cells.
    Benito-Miguel M, García-Carmona Y, Balsa A, Pérez de Ayala C, Cobo-Ibáñez T, Martín-Mola E, Miranda-Carús ME.
    J Immunol; 2009 Dec 15; 183(12):8268-79. PubMed ID: 20007590
    [Abstract] [Full Text] [Related]

  • 38. Generation of interleukin-2-dependent T cell lines from synovial fluids in rheumatoid arthritis.
    Wilkins JA, Olivier SL, Warrington RJ.
    Clin Exp Immunol; 1984 Oct 15; 58(1):1-6. PubMed ID: 6332690
    [Abstract] [Full Text] [Related]

  • 39. HLA-DR4Dw4-restricted T cell recognition of self antigen(s) in the rheumatoid synovial compartment.
    Devereux D, O'Hehir RE, McGuire J, van Schooten WC, Lamb JR.
    Int Immunol; 1991 Jul 15; 3(7):635-40. PubMed ID: 1911537
    [Abstract] [Full Text] [Related]

  • 40. Basis for defective responses of rheumatoid arthritis synovial fluid lymphocytes to anti-CD3 (T3) antibodies.
    Lotz M, Tsoukas CD, Robinson CA, Dinarello CA, Carson DA, Vaughan JH.
    J Clin Invest; 1986 Sep 15; 78(3):713-21. PubMed ID: 3091636
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.